“…Recently, various computational approaches had been developed to investigate the purities of tumor biopsies. These methods had successfully utilized the molecular signatures, such as gene expressions (e.g., the ESTIMATE algorithm [2] ), copy number aberrations (e.g., the ABSOLUTE algorithm [3] ) and DNA methylations (e.g., the LUMP algorithm [1] ), to either estimate the purity [4] , [5] , [6] , [7] , or decode the cell compositions of biopsy samples [8] , [9] , [10] , [11] , [12] , [13] , [14] . Despite the high accuracy and consistency demonstrated in these studies, however, the majority of these methods only focused on biopsy samples from the TCGA (The Cancer Genome Atlas) project [15] and very few had been validated outside the TCGA datasets.…”